Onconetix, Inc.
ONCONasdaq
$0.76
↓ -4.0%Jul 17 close · end-of-day
Price
1Y↓ -99.6%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$477,806.99
Enterprise Value
$477,806.99
P/E
0.0
P/S
0.6
P/B
0.0
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$735,198.00
Net Income (TTM)
-$9.7M
Free Cash Flow (TTM)
—
Gross Margin
79.6%
Operating Margin
-2109.9%
Net Margin
—
ROE
—
ROIC
-104.3%
Debt / Equity
—
Net Cash
—
Return 1Y
-99.6%
Company profile
Onconetix, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.
- CEO
- Ralph Schiess
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 12
- Headquarters
- Ohio
- Website
- onconetix.gcs-web.com
Earnings
ONCO Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$21,457.00↓ -78.9%
Diluted EPS-$6.71↓ -97.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | — | $58,465.00 | $2.5M | $815,371.00 |
| Gross profit | — | — | -$1.1M | $1.1M | $632,913.00 |
| Operating income | -$3.4M | -$13.5M | -$36.0M | -$56.5M | -$17.9M |
| Net income | -$3.4M | -$13.4M | -$37.4M | -$58.7M | -$14.0M |
| Diluted EPS | -$1.26 | -$1.10 | -$87.45 | -$1,823.39 | -$16.56 |
| Operating cash flow | -$2.0M | -$8.7M | -$13.6M | -$10.5M | -$9.7M |
| Free cash flow | -$2.0M | -$8.7M | -$13.6M | -$10.5M | — |
| Gross margin | — | — | -1927.9% | 41.8% | 77.6% |
| Operating margin | — | — | -61634.5% | -2238.0% | -2190.0% |
| Net margin | — | — | -63986.5% | -2325.2% | -1721.0% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $704,848.00 | $406,859.00 | $711,976.00 | $101,630.00 | $106,494.00 | $303,651.00 | $303,596.00 | $21,457.00 |
| Gross profit | $100,716.00 | $105,414.00 | $659,968.00 | $45,832.00 | $70,503.00 | $268,894.00 | $247,684.00 | -$1,655.00 |
| Operating income | -$13.6M | -$2.6M | -$29.1M | -$12.6M | -$1.9M | -$2.1M | -$1.3M | -$10.2M |
| Net income | -$14.3M | -$3.8M | -$29.4M | -$8.5M | -$2.4M | -$8.8M | $5.7M | -$4.2M |
| Diluted EPS | -$2,191.59 | -$249.08 | $637.36 | -$227.25 | -$4.76 | -$6.25 | $221.70 | -$6.71 |
| Operating cash flow | -$3.2M | -$1.1M | -$917,647.00 | -$2.0M | -$1.4M | -$3.2M | -$3.1M | -$2.1M |
| Free cash flow | -$3.2M | -$1.1M | -$921,521.00 | — | — | — | — | — |
| Gross margin | 14.3% | 25.9% | 92.7% | 45.1% | 66.2% | 88.6% | 81.6% | -7.7% |
| Operating margin | -1931.6% | -650.3% | -4093.7% | -12369.2% | -1817.4% | -681.5% | -422.1% | -47657.2% |
| Net margin | -2029.8% | -940.7% | -4134.7% | -8408.8% | -2227.8% | -2892.7% | 1867.5% | -19643.4% |
Company news
May 19, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-04-21 | HRT FINANCIAL LLC | Sale | 49,710 | $0.69 | $34,299.90 | filing |
| 2026-04-20 | HRT FINANCIAL LLC | Sale | 94,462 | $0.75 | $70,846.50 | filing |
| 2026-04-17 | HRT FINANCIAL LLC | Buy | 34,636 | $0.73 | $25,284.28 | filing |
| 2026-04-16 | HRT FINANCIAL LLC | Sale | 53,867 | $0.73 | $39,322.91 | filing |
| 2026-04-15 | HRT FINANCIAL LLC | Buy | 92,554 | $0.76 | $70,341.04 | filing |
| 2026-04-14 | HRT FINANCIAL LLC | Buy | 74,350 | $0.77 | $57,249.50 | filing |
| 2025-08-15 | Oakley Andrew John | J | 20 | $0.00 | $0.00 | filing |
| 2025-08-15 | Oakley Andrew John | Award | 618 | $0.00 | $0.00 | filing |
| 2025-08-15 | Tarsh Simon | J | 39 | $0.00 | $0.00 | filing |
| 2025-08-15 | Tarsh Simon | Award | 618 | $0.00 | $0.00 | filing |
| 2025-08-15 | Meier Thomas | J | 39 | $0.00 | $0.00 | filing |
| 2025-08-15 | Meier Thomas | Award | 618 | $0.00 | $0.00 | filing |
| 2025-08-15 | Ramdeen Timothy R. | J | 39 | $0.00 | $0.00 | filing |
| 2025-08-15 | Ramdeen Timothy R. | Award | 618 | $0.00 | $0.00 | filing |
| 2025-07-14 | Altos Venture AG | J | 241,514 | — | — | filing |
Latest 15 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.